ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
Sales | 87 | 46 | 29 | 55 | 11 |
Gross Profit | 87 | 46 | 29 | 55 | 11 |
Operating Expenses | 2,045 | 2,729 | 2,897 | 4,265 | 2,965 |
Operating Income | -1,958 | -2,684 | -2,868 | -4,210 | -2,954 |
Other Income | 104 | 102 | 98 | 83 | 85 |
Pre-tax Income | -1,853 | -2,582 | -2,771 | -4,127 | -2,870 |
Net Income Continuous | -1,853 | -2,582 | -2,771 | -4,127 | -2,870 |
Net Income | $-1,853 | $-2,582 | $-2,771 | $-4,127 | $-2,870 |
EPS Basic Total Ops | -3.60 | -4.68 | -5.04 | -7.92 | -5.76 |
EPS Basic Continuous Ops | -3.44 | -4.79 | -5.15 | -7.95 | -5.60 |
EPS Diluted Total Ops | -3.60 | -4.68 | -5.04 | -7.92 | -5.76 |
EPS Diluted Continuous Ops | -3.44 | -4.79 | -5.15 | -7.95 | -5.60 |
EBITDA(a) | $-1,932 | $-2,658 | $-2,844 | $-4,183 | $-2,928 |